Konferenzen  >  Medizin & Gesundheitswesen  >  Infektiologie

Cognition Conference

We are delighted to extend a warm invitation to the Bacteriology & Infectious Diseases Conference, scheduled to be held in Zurich, Switzerland, from July 21 to 23, 2025. Organized by Cognition Conferences, this event promises three days of insightful discussions under the theme “Advancements in Bacteriology & Infectious Diseases: From Pathogenesis to Global Health Security.”

Tel.: [+44 20 4571 8752];     Email: contact@cognitionconferences.org

bacteriology, infectious diseases, Pathology, Virus, Genetics, Microbiology, Virology, Immunology, Virulence, Bacterium, Listeria monocytogenes, Campylobacter jejuni, Bacillus cereus, Vibrio cholerae, Pseudomonas aeruginosa, Escherichia coli (E. coli), Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Mycobacterium tuberculosis, Clostridium difficile, Salmonella spp., Neisseria gonorrhoeae, Antibiotic resistance, Bacterial biofilms, Bacteriophage therapy, Quorum sensing, Bacterial virulence factors, Host-pathogen interactions, Bacterial secretion systems, CRISPR-Cas systems in bacteria, Plasmid-mediated resistance, Bacterial motility and flagella

Immunologie und Allergie,    Labormedizin

Scientific Organizers: Akiko Iwasaki, Avindra Nath, Hannah Davis, Daniel M. Altmann

This conference dives into the diagnosis, pathophysiology, and treatment of Long COVID and related post-acute infection syndromes (PAIS) including ME/CFS, post-Lyme, and post-viral conditions. Leading experts will tackle mechanisms ranging from viral persistence and autoimmunity to metabolic, neurological, and cardiovascular sequelae, with focus on biomarkers, cohort heterogeneity, and emerging diagnostics and therapeutics. It also explores epidemiology, demographics, machine learning approaches to symptom clustering, and the overlap with neurodegenerative illness. The program includes updates on ongoing clinical trials, animal model development, and strategies for future translational research. The targeted outcome is to catalyze collaborative interactions among researchers, clinicians, and patients from different backgrounds, fostering a proactive and accelerated approach to unraveling the complexities of Long COVID and other PAIS, and formulating effective strategies for diagnosis, treatment, and care.

Email: nathans@keystonesymposia.org

EMBL Heidelberg

Human microbiota – the collection of microbes living in and on our body – have a significant impact on human health and well-being. They have been associated with numerous diseases, yet we are still far from understanding their role in the context of lifestyle and genetics. Various initiatives are underway around the world to survey the human microbiota at several body sites, characterise them, understand their interactions with the human hosts, elucidate their role in diseases, and design possible therapeutic or dietary interventions. There is a new wave of studies mining the human microbiota for health-relevant bioactive compounds, for characterising specific microbial strains and for cataloguing the human microbiota from all across the globe. This conference will provide plentiful opportunities for researchers to learn about and to connect to important developments in studying the human microbiota.

EMBL Events;     Email: events@embl.de

Meningitis Research Foundation

We are delighted to announce that we will be holding our 15th International Meningitis Research Foundation Conference on the 18th-19th November 2025, at the BMA House in London, UK Our world-leading research conference, dedicated to meningitis, invites delegates from around the world to join us for two days of cutting-edge presentations, panel discussions and poster presentations; as well as the opportunity to network.

Senior Research and Events Officer;     Tel.: [+44 333 405 6278];     Email: mariuszk@meningitis.org

Infectious diseases, meningitis, paediatrics, academic, public health, microbiology, biology, epidemiology, genetics, medicine, healthcare, research, vaccinology

Medizin (allgem.), Innere Medizin,    Epidemiologie

Nexovo Group

Nexovo Infectious Diseases 2025 will be a premier event designed to unite professionals, researchers, and thought leaders to delve into the latest developments and innovations in Infectious Diseases.

Infectious Diseases Coronavirus COVID-19 Bacterial Infectious Diseases

Harvard Medical School

The Comprehensive Infectious Disease Update: Prevention, Diagnosis, Treatment : Designed specifically for front-line primary care and urgent care clinicians, this highly rated Harvard Medical School course delivers the latest updates in infectious diseases, with a focus on practical strategies you can use right away in your practice. You'll gain expert guidance to deliver state-of-the-art care; tools to improve diagnosis, treatment, and prevention; updates on recent breakthroughs and emerging infections; and practical solutions to the most common—and and most challenging—ID problems in primary care.

Harvard Medical School Postgraduate Medical Education;     Email: learn@hms.harvard.edu

Harvard, CME, Immunization, Lyme, COVID-19, infection, vaccine, HIV, MRSA, Hepatitis, UTI, STI, pneumonia, flu, gastroenteritis, travel medicine, respiratory, C. difficile, H. pylori, antibiotics, tuberculosis, respiratory, influenza, measles, immunocompromised, resistant, resistance

Medizin (allgem.), Innere Medizin,    Fortbildung für Gesundheitsfachberufe (CME)